Kirkland & Ellis represented the sole overall coordinator and placing agent, China International Capital Corporation Hong Kong Securities Limited, in the transaction.ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (“ImmuneOnco…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
